The 13 analysts offering 12-month price forecasts for Takeda Pharmaceutical Co Ltd have a median target of 24.79, with a high estimate of 30.63 and a low estimate of 19.32. The median estimate represents a +36.58% increase from the last price of 18.15.
The current consensus among 14 polled investment analysts is to Buy stock in Takeda Pharmaceutical Co Ltd. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.15
Reporting Date Oct 28
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.